Usana Health Sciences (NYSE:USNA) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.71 by 2.82 percent. This is a 15.12 percent decrease over earnings of $0.86 per share from the same period last year. The company reported quarterly sales of $249.54 million which beat the analyst consensus estimate of $243.04 million by 2.67 percent. This is a 9.54 percent increase over sales of $227.80 million the same period last year.